PRICE T ROWE ASSOCIATES INC /MD/
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 80255
BALTIMORE, MD
Position in ARCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$247,880
+$17,879 QoQ
Shares Held
36,887
+23.8% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 133 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. ARCT ranks #240 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in ARCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $247,880 | 36,887 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $230,001 | 29,793 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $160,078 | 26,114 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $515,155 | 27,952 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $302,781 | 23,273 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $213,081 | 20,121 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $322,735 | 19,018 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $411,722 | 17,739 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $428,973 | 17,617 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $573,922 | 17,004 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $506,782 | 16,082 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $401,697 | 15,722 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $552,290 | 19,257 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $476,379 | 19,874 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $335,282 | 19,769 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $270,420 | 18,247 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $263,361 | 16,732 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $440,041 | 16,322 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $556,593 | 15,039 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $704,324 | 14,741 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,525,795 | 133,741 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,560,749 | 183,069 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $61,694,125 | 1,422,179 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $30,175,259 | 703,386 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $24,203,701 | 517,837 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||